EVR vs. ABBV

Last updated Apr 1, 2026

Compare and contrast key facts about Evercore Inc. (EVR) and AbbVie Inc. (ABBV).

Performance

EVR vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Evercore Inc. (EVR) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

EVR vs. ABBV - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
EVR Evercore Inc.	-12.04%	24.25%	64.35%	60.59%	-17.60%	26.29%	51.68%	7.39%	-18.93%	33.42%
ABBV AbbVie Inc.	-4.05%	33.08%	18.86%	-0.23%	24.01%	32.43%	27.72%	1.47%	-0.96%	60.07%

Fundamentals

Market Cap EVR : $12.79B ABBV : $385.83B
EPS EVR : $13.80 ABBV : $2.38
PE Ratio EVR : 21.64 ABBV : 91.23
PS Ratio EVR : 3.30 ABBV : 6.30
Total Revenue (TTM) EVR : $3.88B ABBV : $61.16B
Gross Profit (TTM) EVR : $3.05B ABBV : $44.85B
EBITDA (TTM) EVR : $789.94M ABBV : $28.29B

Returns By Period

In the year-to-date period, EVR achieves a -12.04% return, which is significantly lower than ABBV's -4.05% return. Over the past 10 years, EVR has outperformed ABBV with an annualized return of 21.62%, while ABBV has yielded a comparatively lower 19.07% annualized return.

EVR

• 1D: 4.66%
• 1M: -3.34%
• YTD: -12.04%
• 6M: -11.04%
• 1Y: 51.18%
• 3Y*: 39.44%
• 5Y*: 19.25%
• 10Y*: 21.62%

ABBV

• 1D: 2.05%
• 1M: -6.29%
• YTD: -4.05%
• 6M: -4.63%
• 1Y: 7.29%
• 3Y*: 15.00%
• 5Y*: 19.40%
• 10Y*: 19.07%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

EVR vs. ABBV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EVR

EVR Risk / Return Rank: 75
EVR Sharpe Ratio Rank: 79
EVR Sortino Ratio Rank: 71
EVR Omega Ratio Rank: 74
EVR Calmar Ratio Rank: 75
EVR Martin Ratio Rank: 75

ABBV

ABBV Risk / Return Rank: 50
ABBV Sharpe Ratio Rank: 52
ABBV Sortino Ratio Rank: 44
ABBV Omega Ratio Rank: 44
ABBV Calmar Ratio Rank: 56
ABBV Martin Ratio Rank: 55

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EVR vs. ABBV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Evercore Inc. (EVR) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	EVR	ABBV	Difference
Sharpe ratio Return per unit of total volatility	1.17	0.27	+0.89
Sortino ratio Return per unit of downside risk	1.63	0.54	+1.09
Omega ratio Gain probability vs. loss probability	1.24	1.07	+0.17
Calmar ratio Return relative to maximum drawdown	1.71	0.53	+1.18
Martin ratio Return relative to average drawdown	4.55	1.17	+3.38
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

EVR vs. ABBV - Sharpe Ratio Comparison

The current EVR Sharpe Ratio is 1.17, which is higher than the ABBV Sharpe Ratio of 0.27. The chart below compares the historical Sharpe Ratios of EVR and ABBV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	EVR	ABBV	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.17	0.27	+0.89
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.54	0.86	-0.32
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.59	0.74	-0.15
Sharpe Ratio (All Time) Calculated using the full available price history	0.39	0.74	-0.35

Correlation

The correlation between EVR and ABBV is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

EVR vs. ABBV - Dividend Comparison

EVR's dividend yield for the trailing twelve months is around 1.13%, less than ABBV's 3.06% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
EVR Evercore Inc.	1.13%	0.98%	1.14%	1.75%	2.60%	1.95%	2.14%	3.00%	2.66%	1.58%	1.85%	2.13%
ABBV AbbVie Inc.	3.06%	2.87%	3.49%	3.82%	3.49%	3.84%	4.41%	4.83%	3.89%	2.65%	3.64%	3.41%

Drawdowns

EVR vs. ABBV - Drawdown Comparison

The maximum EVR drawdown since its inception was -81.49%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for EVR and ABBV.

Drawdown Indicators

	EVR	ABBV	Difference
Max Drawdown Largest peak-to-trough decline	-81.49%	-45.09%	-36.40%
Max Drawdown (1Y) Largest decline over 1 year	-30.08%	-16.74%	-13.34%
Max Drawdown (5Y) Largest decline over 5 years	-49.61%	-21.92%	-27.69%
Max Drawdown (10Y) Largest decline over 10 years	-67.42%	-45.09%	-22.33%
Current Drawdown Current decline from peak	-21.88%	-9.64%	-12.24%
Average Drawdown Average peak-to-trough decline	-20.94%	-10.70%	-10.24%
Ulcer Index Depth and duration of drawdowns from previous peaks	11.28%	8.12%	+3.16%

Volatility

EVR vs. ABBV - Volatility Comparison

Evercore Inc. (EVR) has a higher volatility of 12.59% compared to AbbVie Inc. (ABBV) at 7.57%. This indicates that EVR's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	EVR	ABBV	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.59%	7.57%	+5.02%
Volatility (6M) Calculated over the trailing 6-month period	28.29%	19.03%	+9.26%
Volatility (1Y) Calculated over the trailing 1-year period	44.14%	27.12%	+17.02%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	35.57%	22.61%	+12.96%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	36.79%	25.71%	+11.08%

Financials

EVR vs. ABBV - Profitability Comparison

The chart below illustrates the profitability comparison between Evercore Inc. and AbbVie Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

EVR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Evercore Inc. reported a gross profit of 485.28M and revenue of 1.30B. Therefore, the gross margin over that period was 37.4%.

ABBV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, AbbVie Inc. reported a gross profit of 13.96B and revenue of 16.62B. Therefore, the gross margin over that period was 84.0%.

EVR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Evercore Inc. reported an operating income of 430.22M and revenue of 1.30B, resulting in an operating margin of 33.2%.

ABBV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, AbbVie Inc. reported an operating income of 5.81B and revenue of 16.62B, resulting in an operating margin of 35.0%.

EVR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Evercore Inc. reported a net income of 203.95M and revenue of 1.30B, resulting in a net margin of 15.7%.

ABBV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, AbbVie Inc. reported a net income of 1.82B and revenue of 16.62B, resulting in a net margin of 10.9%.